In8bio Competitors

INAB Stock  USD 1.99  0.03  1.53%   
In8bio Inc competes with Transcode Therapeutics, Aptevo Therapeutics, HCW Biologics, Lyra Therapeutics, and Kiora Pharmaceuticals; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing In8bio competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of In8bio to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out In8bio Correlation with its peers.

In8bio vs Phio Pharmaceuticals Correlation

Very good diversification

The correlation between In8bio Inc and PHIO is -0.34 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding In8bio Inc and PHIO in the same portfolio, assuming nothing else is changed.

Moving against In8bio Stock

  0.55ORGN Origin MaterialsPairCorr
  0.54HPQ HP IncPairCorr
  0.32T ATT Inc Earnings Call TomorrowPairCorr
  0.31TRV The Travelers CompaniesPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.101.999.18
Details
Intrinsic
Valuation
LowRealHigh
0.091.879.06
Details
Naive
Forecast
LowNextHigh
0.031.638.82
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.892.272.65
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as In8bio. Your research has to be compared to or analyzed against In8bio's peers to derive any actionable benefits. When done correctly, In8bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in In8bio Inc.

In8bio Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between In8bio and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of In8bio and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of In8bio Inc does not affect the price movement of the other competitor.

High positive correlations

HCWBAPVO
APREHCWB
APREAPVO
PHIOHCWB
PHIOAPRE
ACXPLYRA
  

High negative correlations

PHIOGLTO
APREGLTO
GLTOHCWB
GLTOAPVO
ACXPGLTO
APRERNAZ

Risk-Adjusted Indicators

There is a big difference between In8bio Stock performing well and In8bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze In8bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RNAZ  4.22 (0.42) 0.00 (0.24) 0.00 
 8.35 
 34.47 
APVO  4.71 (1.97) 0.00 (1.95) 0.00 
 6.67 
 43.37 
HCWB  5.17 (1.59) 0.00 (0.84) 0.00 
 13.02 
 41.72 
LYRA  5.54 (1.23) 0.00 (1.31) 0.00 
 13.48 
 66.89 
KPRX  2.47 (0.07) 0.00 (0.01) 0.00 
 4.44 
 16.69 
GLTO  11.56  4.50  0.54  0.61  6.83 
 17.97 
 273.14 
APRE  3.97 (0.98) 0.00 (0.42) 0.00 
 4.40 
 41.84 
ACXP  4.46 (1.24) 0.00 (0.61) 0.00 
 10.84 
 49.19 
BCDA  2.43 (0.23) 0.00 (0.12) 0.00 
 5.74 
 17.38 
PHIO  2.99 (0.79) 0.00 (0.40) 0.00 
 4.88 
 19.15 

In8bio Competitive Analysis

The better you understand In8bio competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, In8bio's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across In8bio's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
INAB RNAZ APVO HCWB LYRA KPRX GLTO APRE ACXP BCDA
 1.53 
 1.99 
In8bio
 3.44 
 8.98 
Transcode
 10.34 
 6.76 
Aptevo
 4.31 
 1.11 
HCW
 1.98 
 1.98 
Lyra
 3.42 
 2.26 
Kiora
 6.40 
 25.61 
Galecto
 10.67 
 0.67 
Aprea
 4.20 
 2.28 
Acurx
 4.13 
 1.16 
Biocardia
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
EBITDA
Current Valuation
Price To Book
Operating Margin
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

In8bio Competition Performance Charts

Five steps to successful analysis of In8bio Competition

In8bio's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by In8bio Inc in relation to its competition. In8bio's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of In8bio in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact In8bio's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to In8bio Inc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your In8bio position

In addition to having In8bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tips ETFs Thematic Idea Now

Tips ETFs
Tips ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Tips ETFs theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tips ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:
Check out In8bio Correlation with its peers.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. Market participants price In8bio higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive In8bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, In8bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.